1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Banner Corporation signed a merger agreement on April 30, 2026, to acquire Pacific Financial Corporation, the holding company for Bank of the Pacific, in an all-stock transaction. The companies said the combined company is expected to have about $18 billion in assets, and the deal is expected to close in the third quarter of 2026, subject to shareholder and regulatory approvals.
Each Pacific Financial share converts into 0.2633 Banner shares; the companies cite an implied $17.44 per share based on Banner's $66.25 close on April 29, 2026.
The transaction is valued at about $177 million; Pacific Financial shareholders are expected to own about 7% of the combined company.
Pacific Financial must pay Banner a $6.3 million termination fee in certain circumstances.
Closing requires approval by two-thirds of Pacific Financial shareholders and regulatory approvals, including from the Federal Reserve Board and the FDIC; the companies expect closing in the third quarter of 2026.
Perrigo completed the sale of its Dermacosmetics branded business to Karo Healthcare on April 30, 2026. Karo paid €305.6 million in upfront cash, including €5.6 million in net working capital adjustments, with up to €27.0 million more contingent on net sales milestones over three years. The company says the net proceeds will be used primarily to reduce debt.
Closed April 30, 2026, with upfront cash of €305.6 million, including €5.6 million in net working capital adjustments
Up to €27.0 million in additional contingent consideration, tied to net sales milestones over three years
Net proceeds expected to be used primarily to reduce debt, according to CEO Patrick Lockwood-Taylor
Business generated about €120 million in net sales in calendar 2025, or about 5% of adjusted operating income
Spire Inc. completed the sale of Spire Marketing Inc., its gas marketing subsidiary, to Boardwalk Pipelines, LP on April 30, 2026, for $215.0 million in cash, subject to customary post-closing adjustments. The company said the proceeds partly fund its acquisition of the Piedmont Natural Gas Tennessee business and general corporate purposes, and that the sale sharpens its focus on regulated natural gas utilities.
Sale price: $215 million in cash, subject to customary post-closing adjustments
Transaction completed and effective April 30, 2026, following the March 28, 2026 purchase agreement
Spire Marketing employees and clients move to Boardwalk Continuum Marketing, LLC; Pat Strange continues as president
Proceeds used to partially fund the Piedmont Natural Gas Tennessee business acquisition and for general corporate purposes
SM Energy completed the sale of about 61,000 net acres in Webb County, Texas, to Caturus Energy on April 30, 2026, for a cash purchase price of $950 million, with net cash proceeds of about $900 million after preliminary adjustments. The company plans to use the proceeds to redeem in full $819 million of its 2026 senior notes at par, which it says advances its $1.0 billion-plus divestiture target and its goal of strengthening the balance sheet.
Sale of about 61,000 net acres in Webb County, Texas, to Caturus Energy closed April 30, 2026, under a purchase agreement signed February 17, 2026.
Net cash proceeds of about $900 million; the final purchase price remains subject to customary post-closing adjustments.
Planned full redemption at par of $819 million of 2026 senior notes: $419 million of 6.75% notes (June 1, 2026) and $400 million of 5.0% notes (May 11, 2026).
Lender commitments of $2.5 billion and a borrowing base of $5.0 billion were reaffirmed after the sale.
On April 29, 2026, Belden Inc. agreed to buy the RUCKUS reporting segment of Vistance Networks for about $1.846 billion in cash, on a cash-free, debt-free basis, funded with cash on hand and committed debt financing. Closing is expected in the second half of 2026, subject to regulatory clearances and other conditions. Belden said it will temporarily pause share repurchases to prioritize reducing net leverage, a trade-off shareholders should weigh against the expected growth and margin benefits.
Purchase price of about $1.846 billion in cash, cash-free and debt-free, subject to adjustments
Closing expected in the second half of 2026; outside date January 31, 2027, extendable by three months if only regulatory approvals are outstanding
Belden expects net leverage below 3.0x within the first full year after close and about 1.5x by 2029
Belden intends to temporarily pause share repurchases until leverage returns closer to its long-term target
MARA agreed on April 29, 2026, to buy 100% of Long Ridge Energy & Power LLC from FTAI Infrastructure-linked sellers for a base purchase price of approximately $1.5 billion, subject to customary adjustments. The plant, a gas-fired power facility in Hannibal, Ohio, sits beside a data center that MARA already operates, and the deal is expected to close in the second half of 2026, subject to regulatory approvals and other conditions.
Base purchase price of approximately $1.5 billion; the press release says total transaction value includes the assumption of at least $785 million of debt.
Barclays committed to provide a 364-day senior secured bridge term loan of up to $785,000,000 to the Company.
Buyer may owe a $75.0 million termination fee in certain circumstances; either party may terminate after November 30, 2026 (or June 30, 2027 if certain regulatory conditions are not met).
Closing is subject to Hart-Scott-Rodino clearance and Federal Energy Regulatory Commission approval.
SIM Acquisition Corp. I, a blank check company, entered a non-binding letter of intent on April 26, 2026 to acquire 100% of the equity of American Industrial Technologies, Inc. (AIT), a Nevada telecommunications and logistics company, through a proposed deSPAC business combination. The LOI is not binding on the deal terms, which remain subject to definitive agreements, due diligence, approvals and closing conditions, and the filing states there is no assurance a transaction will be completed.
LOI dated April 26, 2026; 100% of AIT's outstanding equity and equity equivalents would be acquired
Initial 45-day exclusivity period, renewable for one additional 15-day period if negotiations continue in good faith
Only confidentiality, expenses, exclusivity, trust waiver, termination, governing law, jurisdiction, jury waiver and miscellaneous provisions are binding
No financial terms, valuation or purchase price are disclosed in the filing
Gilead Sciences completed its acquisition of Arcellx, Inc. on April 28, 2026, paying $115 per share in cash plus one contingent value right of $5 per share, for a total implied equity value of about $7.8 billion. Gilead said the deal will reduce its GAAP and non-GAAP 2026 diluted EPS by approximately $5.57 to $5.67, so shareholders face a large near-term earnings charge tied to the anito-cel program's future success.
Acquisition completed April 28, 2026, after tender offer expired April 27 with about 77.2% of Arcellx shares outstanding tendered or already owned by Gilead
Total funds used were approximately $7.1 billion; implied equity value at closing was about $7.8 billion
Gilead expects 2026 diluted EPS to fall by approximately $5.57 to $5.67; excluding acquired in-process R&D, it expects modest dilution in 2026 and 2027 and accretion from 2028, subject to FDA approval of anito-cel
CVR pays $5 per share if cumulative global net sales of anito-cel reach at least $6.0 billion from launch through 2029
Brookfield Oaktree Holdings, LLC completed a distribution in kind on April 20, 2026, transferring 100% of its equity interests in OCG NTR Holdings LLC to its affiliate Brookfield Oaktree Holdings Canada Inc. under a Distribution Agreement dated the same day. The filing says the transfer covers indirect interests in entities that include Brookfield Real Estate Income Trust Inc., a Maryland corporation. The filing does not describe financial terms, valuation, or effects on the company's results.
Distribution Agreement dated April 20, 2026, between BOH and Brookfield Oaktree Holdings Canada Inc. (BOHCI)
BOH distributed 100 Common Shares of OCG NTR Holdings LLC, representing 100% of its equity interests in NTR
The distribution was completed on April 20, 2026, in respect of BOH's Class A common units
The 8-K was signed by CFO Daniel D. Levin on April 27, 2026
On April 27, 2026, Ligand Pharmaceuticals agreed to acquire XOMA Royalty Corporation for $39.00 per share in cash plus one contingent value right per share, for a total equity value of approximately $739 million. Ligand raised its 2026 revenue and adjusted EPS guidance at the same time. The deal requires XOMA Royalty stockholder approval and Hart-Scott-Rodino clearance and is expected to close in the third quarter of 2026.
Cash price of $39.00 per share; each CVR entitles holders to a portion of 75% of net proceeds from XOMA's litigation with Janssen Biotech over TREMFYA.
Ligand raised 2026 revenue guidance to $270 million to $310 million (from $245 million to $285 million) and adjusted EPS guidance to $8.50 to $9.50 (from $8.00 to $9.00).
XOMA Royalty must pay a $40,000,000 termination fee in specified circumstances; the merger outside date is January 26, 2027.
Entities affiliated with BVF Partners, holding about 21% of XOMA Royalty common stock, agreed to support the transaction.
BioMarin completed its all-cash acquisition of Amicus Therapeutics on April 27, 2026, at $14.50 per share, for a total equity value of approximately $4.8 billion. The company funded the deal with $2.0 billion and $800 million term loans under a new credit agreement, plus proceeds from previously issued 5.500% senior notes due 2034 and cash on hand, and it expects to provide updated FY 2026 guidance on May 4, 2026.
Amicus shareholders receive $14.50 per share in cash, and Amicus equity awards were cashed out or cancelled at the same price.
New credit agreement with Citibank, N.A. as administrative agent includes a $2.0 billion Term Loan B, an $800.0 million Term Loan A and a $600.0 million revolver, with the revolver undrawn at closing.
Term Loan B matures on the seventh anniversary of closing; Term Loan A and the revolver mature on the fifth anniversary.
BioMarin expects to provide updated FY 2026 guidance during its first quarter earnings call on May 4, 2026.
Miluna Acquisition Corp, a special purpose acquisition company listed on Nasdaq, signed a definitive business combination agreement on April 23, 2026 with Kukugan Invest and CADV Ventures S.A., an AI software company based in Poland. Under the agreement, Miluna would issue new Class A shares valued at $250 million to Kukugan Invest at a $10.00 per share reference price, and the combined company would be renamed Kukugan Corp. The deal is expected to close in the second half of 2026, subject to approval by Miluna shareholders, so existing Miluna shareholders would be diluted if it completes.
Aggregate transaction consideration of $250 million, paid in newly issued Class A shares at a $10.00 per share reference price.
Up to 5,000,000 additional Class A earn-out shares, issuable if the surviving company reports consolidated revenue of at least $7 million for fiscal 2027.
Class B shares carrying 15 votes per share are issued to a designated individual, with no economic rights, and are not convertible.
Press release cites a pre-money equity value of $300 million and an implied pro forma enterprise value of about $408 million, assuming no redemptions by public shareholders.
Organon agreed on April 26, 2026 to be acquired by Sun Pharma entities in an all-cash merger valued at an enterprise value of $11.75 billion. The $14.00 per share price represents a 103% premium to the closing share price on April 9, 2026, and the deal requires Organon stockholder approval and regulatory clearances.
Organon stockholders would receive $14.00 per share in cash, a 103% premium to the April 9, 2026 closing price
Enterprise value of the deal is $11.75 billion; Sun Pharma plans to fund it with available cash and committed bank financing
The transaction is expected to close in early 2027 and can be terminated if the merger is not completed by January 26, 2027
If completed, Organon shares would be delisted from the New York Stock Exchange
Hornbeck Offshore Services and Helix Energy Solutions Group signed a merger agreement on April 22, 2026, under which Hornbeck becomes a subsidiary of Helix and the combined company takes the Hornbeck name and stays listed on the NYSE. Hornbeck shareholders would own about 55% of the combined company on a fully diluted basis, and each Hornbeck share would convert into 10.27167 shares of the combined company. Closing depends on conditions including approval by Helix shareholders and regulatory clearances.
Merger Agreement dated April 22, 2026, among Helix Energy Solutions Group, Hornbeck Offshore Services and related subsidiaries
Each Hornbeck common share converts into 10.27167 shares of Helix common stock at the effective time
Hornbeck shareholders would own about 55% and Helix shareholders about 45% of the combined company, fully diluted
Majority of Hornbeck stockholders adopted the merger agreement by written consent; closing requires Helix shareholder approval, an effective Form S-4, and HSR antitrust waiting period expiration
On April 22, 2026, Axos Bank, a subsidiary of Axos Financial, agreed to acquire individual retirement accounts from Capital One, National Association, with an aggregate deposit balance of about $3.2 billion, along with certain related assets and liabilities. The bank will pay cash equal to the deposit balance less a negotiated premium, and the filing does not disclose the premium amount because it is redacted. The deal requires approval from the Office of the Comptroller of the Currency and is expected to close later in calendar year 2026.
Acquired IRAs have an aggregate balance of approximately $3.2 billion in associated savings and certificate of deposit accounts.
Purchase price equals the aggregate deposit balance less a negotiated premium; the premium amount is redacted in Exhibit 99.1.
Closing is subject to Office of the Comptroller of the Currency approval and is expected later in calendar 2026.
Agreement is dated April 22, 2026, with Capital One, National Association; the 8-K was filed April 23, 2026.
Spire Inc. (NYSE: SR) said its subsidiary Spire EnergySouth agreed on April 21, 2026 to sell Spire Mississippi, a natural gas utility serving about 18,000 customers, to Delta Utilities for $75 million in cash. The sale is subject to Mississippi Public Service Commission approval and is expected to close in the first fiscal quarter of 2027; Spire plans to use the proceeds to fund infrastructure investments in Alabama, Missouri and Tennessee.
Purchase price of $75 million, subject to adjustments; the press release cites a 1.4x multiple of 2025 rate base
Spire Mississippi has about 745 miles of distribution pipelines and about 18,000 customers in south-central Mississippi
If the deal is terminated under qualifying circumstances, Purchaser would pay a reverse termination fee of $7.5 million
Closing expected in the first fiscal quarter of 2027, subject to MPSC approval
Certara agreed on April 21, 2026 to sell its global medical writing and related regulatory services business to Veristat for $100 million in cash, plus up to $35 million in earn-out payments tied to the business's performance after closing. The company expects the sale to close in the second quarter of 2026 and plans to update its 2026 guidance at that time, so shareholders will not see the sale's full effect on guidance until then.
Cash consideration of $100 million, subject to post-closing adjustments for working capital, indebtedness and transaction expenses
Up to $35 million in contingent earn-out payments based on the business's financial performance after closing
Up to $15 million of the closing payment may be held in escrow if certain items are not satisfied at closing
The business generated $50 million in revenue and $17 million in adjusted EBITDA in 2025; closing is expected in the second quarter of 2026
Amneal agreed on April 21, 2026 to acquire 100% of Kashiv BioSciences, LLC for $375 million in cash and 28,942,108 Class A shares at closing, plus up to $350 million in contingent regulatory milestone payments and royalties. The same day, Amneal reported preliminary first quarter 2026 results showing higher revenue, net income and EPS, and raised its 2026 adjusted EBITDA and adjusted diluted EPS guidance.
Consideration: $375 million cash and 28,942,108 Class A shares at closing, plus up to $350 million in contingent regulatory milestone payments; closing expected in the second half of 2026 and requires Amneal shareholder approval.
Preliminary Q1 2026 (unaudited): consolidated net revenue $723 million, up 4% from $695 million; net income $78 million versus $25 million; diluted EPS $0.19 versus $0.04.
Raised 2026 adjusted EBITDA guidance to $740 million-$770 million from $720 million-$760 million; adjusted diluted EPS to $0.95-$1.05 from $0.93-$1.03; net revenue guidance unchanged at $3.05 billion-$3.15 billion.
Acquisition agreement has an outside date of November 17, 2026, extendable to January 12, 2027 if only certain regulatory approvals remain outstanding.
NHC's subsidiary NHC/OP, L.P. agreed to buy the land and buildings of 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. (NHI), which NHC currently leases under a Master Agreement to Lease. NHC can terminate the agreement for any reason through a review period ending May 29, 2026, with substantially all of its initial $5 million deposit refunded, and the deal is expected to close in the third quarter of 2026. NHC's chief executive says the deal is expected to be accretive to earnings and cash flow, but the filing gives no earnings or cash flow figures.
Purchase price is $560 million, subject to adjustment, payable at closing, with no financing contingencies; NHC expects to fund part of it with a new credit facility.
A $5 million initial deposit is due within five business days; an additional $15 million deposit is due within seven business days after the review period ends on May 29, 2026, if NHC has not terminated.
NHC will keep operating the facilities except four Florida skilled nursing facilities, which are subleased to a third-party operator; the Master Lease will be terminated for the other facilities at closing.
Closing is expected in the third quarter of 2026, subject to Hart-Scott-Rodino antitrust waiting period and other conditions; NHC's chairman Robert G. Adams sits on NHI's board and is not standing for reelection there.
CVB Financial Corp. completed its all-stock merger with Heritage Commerce Corp on April 17, 2026, with Heritage merging into CVBF and Heritage Bank of Commerce merging into Citizens Business Bank. The company said Citizens' total assets will exceed $20 billion, and it issued about 41 million CVBF shares to former Heritage shareholders, which dilutes existing holders.
Merger closed April 17, 2026; each Heritage share was converted into 0.65 CVBF shares.
About 41 million CVBF common shares were issued to former Heritage shareholders.
R. Clay Jones, formerly Heritage's CEO, was appointed President of CVBF and Citizens; David A. Brager remains CEO.
Jones' employment agreement includes a $700,000 annual base salary and a $1,800,000 cash retention award.
Brady Corporation agreed on April 20, 2026 to acquire Honeywell's Productivity Solutions and Services business for $1.4 billion in cash, with closing expected in the second half of calendar 2026. The company plans to fund the deal with new debt and cash on hand, and BMO Capital Markets has committed up to $1.8 billion in bridge financing. For shareholders, the business generated about $1.1 billion of sales in 2025, and Brady expects net debt-to-EBITDA of about 2.5 times after transaction financing, deleveraging to below 2.0 times within two years of closing.
Base purchase price of $1.4 billion in cash, subject to customary adjustments; closing expected in the second half of calendar 2026 and subject to regulatory approvals.
BMO Capital Markets committed bridge facilities of up to $1.8 billion: a $1 billion Tranche A and an $800 million Tranche B.
PSS generated sales of approximately $1.1 billion in 2025, compared with Brady's fiscal 2025 sales of approximately $1.51 billion.
Brady expects a minimum of $25 million in annual run-rate cost synergies within three years of closing; the filing states the deal is financed with new debt and cash on hand.
National Health Investors agreed to sell 32 skilled nursing facilities and three independent living facilities to its lessee, National HealthCare Corporation, for $560.0 million. The company expects to close on July 1, 2026, subject to customary conditions including the Hart-Scott-Rodino waiting period, and plans to use net proceeds to repay borrowings and fund future investments. The filing says the 35 properties generated about $39.7 million of cash lease revenue in 2025, so shareholders will lose that income stream while gaining proceeds to reduce debt.
Sale of 32 skilled nursing facilities and three independent living facilities to NHC for $560.0 million.
Anticipated closing date of July 1, 2026, subject to customary conditions and HSR waiting period expiration or termination.
The 35 properties generated approximately $39.7 million of cash lease revenue in 2025, including percentage rent.
Expected transaction costs of $6.0 to $8.0 million; pro forma net debt-to-annualized EBITDA of about 2.3x and available liquidity of about $1.4 billion.
United Community Banks (NYSE: UCB) reported first-quarter 2026 net income of $84.3 million and diluted EPS of $0.69, up $0.11 from a year earlier but down $0.01 from the fourth quarter. The bank also announced a definitive merger agreement to acquire Peach State Bancshares, Inc., with deal details in a separate presentation filed with the SEC.
Q1 2026 net income $84.3 million, up $12.9 million from Q1 2025; GAAP diluted EPS $0.69 vs. $0.58; operating EPS $0.70, up 19%
Total revenue $276.5 million, up 12% from a year earlier
Definitive merger agreement to acquire Peach State Bancshares, Inc. announced April 21, 2026
Repurchased 1.09 million shares at an average price of $33.97; plans to redeem remaining $100 million of subordinated debentures in Q2 2026
Onto Innovation agreed to acquire 61,123,436 shares, or 27%, of Rigaku Holdings from an affiliate of The Carlyle Group for about $710 million, with closing expected in the second half of 2026. The company also obtained a commitment for a $500 million 364-day bridge loan from Goldman Sachs Bank USA to help finance the deal, which adds a large investment and new debt financing for shareholders to weigh.
Purchase price of approximately $710 million for 27% of Rigaku common stock, agreed April 21, 2026 (Tokyo time)
Transaction expected to close in the second half of 2026, subject to regulatory approvals and customary conditions
Bridge Commitment Letter with Goldman Sachs Bank USA provides up to $500 million senior secured 364-day term loan
Company expects to account for the minority stake under the fair value option and not consolidate Rigaku results; termination fee of 2% of the purchase price applies in certain cases
Brookfield Oaktree Holdings, LLC entered into a Transaction Agreement on April 14, 2026, under which all outstanding limited partnership interests and equity awards of Oaktree Capital Group Holdings, Oaktree Equity Plan and Oaktree Equity Plan II will be acquired or cancelled. The consideration may include cash, Class A Limited Voting Shares of BAM or BN, ExchangeCo limited partnership interests, and BAM restricted stock units. The filing says the terms will not affect the company's 6.625% Series A and 6.550% Series B preferred units, and the deal is subject to customary closing conditions, including required regulatory approvals.
Agreement dated April 14, 2026, with Acquisition Z (2026) LP and other parties, including Brookfield Asset Management Ltd. and Brookfield Corporation for limited purposes.
Consideration may be cash, BAM Class A or BN Class A shares, ExchangeCo limited partnership interests, BAM RSUs, or a combination.
Brookfield US Company LLC would buy all interests in Oaktree Capital I GP, LLC, in which BOH holds an approximately 74% economic interest before the Transactions.
Either party may terminate if the Transactions do not close before January 14, 2027.
ESCO Technologies agreed on April 15, 2026 to buy Megger Group Limited from TBG AG for about $2.35 billion, consisting of $922 million in cash and 5.10 million new ESCO common shares, subject to a cash post-closing adjustment. Closing depends on US antitrust, national security and foreign approvals, and the deal can be terminated if closing conditions are not met by April 15, 2027.
Purchase price is about $2.35 billion: $922 million in cash plus 5.10 million ESCO common shares
ESCO obtained a Commitment Letter from JPMorgan Chase Bank, N.A. for up to $1,500 million in best-efforts senior secured facilities, with a $975 million bridge loan as a fallback
After closing, TBG AG would have the right to one board seat while it holds at least 50% of the consideration shares
Closing requires approvals under HSR, CFIUS and DCSA, plus foreign merger control and investment laws
ESCO Technologies agreed to acquire the Megger Group business of TBG AG for total consideration of $2.35 billion, made up of $0.9 billion in cash and ESCO equity valued at about $1.4 billion. The company also said preliminary second-quarter 2026 results were above its prior guidance, with revenue of $309 million, GAAP EPS of $1.29 and adjusted EPS of $1.91.
Deal value: $2.35 billion, including $0.9 billion in cash and about $1.4 billion in ESCO equity; cash to come from cash on hand and incremental debt, with committed financing in place
Megger is expected to have about $590 million in revenue in 2026; the deal values it at about 14x projected 2026 EBITDA, including synergies
Expected cost synergies of about $60 million within three years of closing; TBG would receive one board seat after closing
Preliminary Q2 2026: revenue $309 million, GAAP EPS $1.29, adjusted EPS $1.91; full results and outlook update due after the market close on May 7, 2026
On April 14, 2026, Owens Corning amended its agreement to sell most of its global glass reinforcements business, citing changing market conditions. The enterprise value fell from $755 million to $645 million, and the company expects an additional loss on sale of about $140 million. The company still expects about $280 million in after-tax net proceeds and plans to close in the second quarter of 2026.
Revised enterprise value of $645 million, down from $755 million in the original agreement
Additional loss on sale of approximately $140 million expected
$30 million non-refundable deposit received from the Purchasers; about $280 million in after-tax net proceeds expected
Transaction expected to close in the second quarter of 2026
On April 9, 2026, Trinity's subsidiary Trinity Industries Leasing Company contributed its interests in TRIP Rail Holdings and Triumph Rail Holdings to NP SPE Holdings in exchange for an 11.2% limited partnership interest in NP SPE. Trinity says TRIP Holdings and its subsidiaries will no longer be consolidated into its financial statements, so the change affects how the company's reported results are presented.
Agreement dated April 9, 2026, with TRIP Rail Holdings, Triumph Rail Holdings, NP SPE Holdings LP and Napier Park Rail Evergreen Fund GP LLC
Trinity contributed a 42.56% membership interest in TRIP Rail Holdings and a 0.2% interest in Triumph Rail Holdings
In return, Trinity received an 11.2% limited partnership interest in NP SPE Holdings LP
TRIP Holdings and its subsidiaries will no longer be consolidated in Trinity's financial statements
Spire Inc. agreed on April 14, 2026 to sell Belle Butte LLC, which owns the Spire Storage West facility in Wyoming and the Spire Storage Salt Plains facility in Oklahoma, to an affiliate of I Squared Capital. The total consideration is $650 million, including $600 million in cash at closing, and the sale is expected to partly fund Spire's Piedmont Natural Gas Tennessee acquisition. Spire said it will provide revised fiscal 2026 guidance in May and continues to expect fiscal 2027 adjusted EPS of $5.40 to $5.60.
Cash purchase price of $600 million at closing, plus a $50 million deferred payment due on or before September 2027
Storage West has up to 55 Bcf of working gas capacity and Salt Plains has up to 17 Bcf
Closing expected in the second half of fiscal 2026, subject to Hart-Scott-Rodino review and other conditions
Spire expects to give revised 2026 adjusted EPS guidance on its May earnings call; fiscal 2027 guidance of $5.40 to $5.60 is unchanged
Leidos agreed on April 14, 2026 to combine its Security Enterprise Solutions and Industrial Automation businesses with Analogic, a portfolio company of Altaris, in a new joint venture. Leidos will hold 41.5% of the joint venture and the Altaris entities will hold 58.5%, and the deal is expected to close in the second half of 2026 subject to regulatory approvals. The filing does not disclose a purchase price, and the press release says Leidos will contribute about $625 million in projected 2026 revenue and roughly 1,500 employees.
Leidos will hold 41.5% of the new joint venture; Altaris-affiliated entities will hold 58.5%
Leidos will contribute about 1,500 employees representing $625 million in projected 2026 revenue
Closing is expected in the second half of 2026, subject to Hart-Scott-Rodino review and other regulatory approvals
Either party may terminate if the deal is not completed by the six-month anniversary of signing, with an automatic three-month extension
Amazon.com and Globalstar signed a definitive merger agreement under which Amazon will acquire Globalstar, adding direct-to-device satellite services to Amazon Leo. The deal is subject to closing conditions including regulatory approvals, and the filing says it is expected to close in 2027, so shareholders face a multi-year transaction with terms that depend on stock prices and milestones.
Globalstar holders can elect $90.00 in cash or 0.3210 Amazon shares per share, with the stock value capped at $90.00
Cash elections are capped at 40% of Globalstar shares, with excess cash converted to stock on a pro rata basis
Total consideration may be reduced by up to $110 million if Globalstar misses certain operational milestones
Holders of about 58% of Globalstar's voting power approved the deal by written consent; Amazon also signed a satellite services agreement with Apple
Credo Technology Group agreed on April 13, 2026 to acquire 100% of DustPhotonics Ltd., an Israeli silicon photonics developer, for upfront consideration of $750 million in cash and about 0.92 million Credo ordinary shares. The deal also allows for up to about 3.21 million additional shares tied to financial milestones, so shareholders would face share issuance and the acquisition is expected to close in the second quarter of calendar 2026, subject to closing conditions and regulatory approvals.
Upfront consideration: $750 million in cash plus about 0.92 million Credo ordinary shares
Contingent consideration: up to about 3.21 million additional shares based on financial milestones
Expected close: second quarter of calendar 2026, subject to regulatory approvals
Credo expects the deal to be accretive to non-GAAP earnings per share in fiscal 2027
On April 13, 2026, Somnigroup signed a merger agreement under which Merger Sub will merge into Leggett & Platt, which would survive as a wholly owned Somnigroup subsidiary. Each Leggett & Platt share would convert into 0.1455 Somnigroup shares, so the deal would issue new Somnigroup stock and affect existing Somnigroup holders' ownership. Closing requires Leggett & Platt stockholder approval, antitrust and other regulatory clearances, and an effective Form S-4, and the boards of both companies have unanimously approved the deal.
Each Leggett & Platt common share would convert into 0.1455 shares of Somnigroup common stock, plus cash in lieu of fractional shares.
Closing requires Leggett & Platt stockholder approval, Hart-Scott-Rodino clearance, and NYSE listing approval for the new Somnigroup shares.
Leggett & Platt would pay Somnigroup a $64 million termination fee in specified cases; Somnigroup would pay Leggett & Platt $80 million in specified antitrust-related cases.
Either party may terminate if the merger is not completed before January 13, 2027, subject to extensions to as late as April 13, 2028.
Leggett & Platt signed a merger agreement under which Somnigroup International will acquire it in an all-stock transaction valued at about $2.5 billion, based on Somnigroup's April 10, 2026 closing share price. Leggett & Platt shareholders will receive 0.1455 Somnigroup shares for each share they own, and would hold about 9% of the combined company, so their future value will depend on Somnigroup's share price and the deal closing.
Exchange ratio: 0.1455 Somnigroup common shares per Leggett & Platt share, with cash only for fractional shares
Expected closing by year-end 2026, subject to Leggett & Platt shareholder approval and regulatory approvals
Outside date January 13, 2027, extendable to April 13, 2028; Leggett & Platt would pay $64 million if it accepts a superior proposal, and Somnigroup would pay $80 million if the deal fails on required approvals
Dynamix Corporation and The Ether Machine, Inc. mutually terminated their Business Combination Agreement dated July 21, 2025, along with the related Sponsor Support Agreement, under a Termination Agreement dated April 8, 2026. Under that agreement, the Payor must pay Dynamix $50 million within 15 days, and the parties exchanged mutual releases. Dynamix still has until November 22, 2026 to complete an initial business combination, or it must redeem its public shares.
Termination Agreement dated April 8, 2026 ends the Business Combination Agreement dated July 21, 2025, and the Sponsor Support Agreement dated July 21, 2025.
The Payor must pay Dynamix $50 million within 15 days of April 8, 2026.
Mutual releases and a covenant not to sue were included; Dynamix has until November 22, 2026 to complete an initial business combination or must redeem public shares.
Ovintiv closed the sale of its Anadarko assets in Oklahoma on April 9, 2026, with the buyer paying $2.9 billion in cash after preliminary closing adjustments. The company said proceeds will go to debt reduction and that the sale achieves its debt target. Ovintiv also plans to repay C$1.57 billion under its Credit Agreement on April 10, 2026 and redeem $700 million of 5.650% notes due 2028 on April 20, 2026.
Buyer MidCon II BuyerCo, LLC paid $2.9 billion in cash after preliminary closing adjustments; the press release cites expected proceeds of about $2.85 billion after customary adjustments
Sold approximately 360,000 net acres in west-central Oklahoma, with an effective date of January 1, 2026
Credit Agreement borrowings of C$1.57 billion to be repaid April 10, 2026, after which the agreement terminates
$700 million aggregate principal of 5.650% notes due 2028 to be redeemed April 20, 2026
On April 7, 2026, Fifth Era Acquisition Corp I (FERA), a special purpose acquisition company, agreed to combine with SMT Holdings Limited, which operates as Miotal, a holder of high-purity strategic metals. Miotal's shares are to be exchanged for Holdco ordinary shares valued at $10 billion, and FERA's Class A and Class B shares are to convert one-for-one into Holdco shares. The filing does not include revenue, profit or earnings figures for Miotal, and closing depends on FERA shareholder approval, a registration statement and Nasdaq listing approval.
Business Combination Agreement dated April 7, 2026, with Miotal SPAC HoldCo, Inc., PENNY Merger Sub, Inc. and SMT Holdings Limited
Miotal shares to be exchanged for Holdco shares valued at $10 billion, with each Holdco share valued at $10.00
Miotal estimates its metals stockpile at about $35 billion at prevailing market prices, which it says may vary substantially
Closing expected in the first half of 2026; sponsor must cover or reduce shares if PENNY Transaction Costs exceed $15,000,000
Mountain Lake Acquisition Corp. II, a blank check company, and quantum technology firm Terra Quantum AG signed a non-binding letter of intent for a business combination that values Terra Quantum at $3.25 billion. The letter does not bind either party, and the filing states there is no assurance a definitive agreement will be signed or the deal completed.
Proposed deal values Terra Quantum AG at $3.25 billion, per the April 9, 2026 press release
Letter of intent is non-binding; completion depends on a definitive agreement and conditions not yet negotiated
Any transaction would require due diligence, board and shareholder approvals, and regulatory approvals
MLAC II's Class A Ordinary Shares trade on Nasdaq under the ticker MLAA
On April 8, 2026, Equitable Holdings entered a Voting and Support Agreement with Nippon Life Insurance Company and Corebridge Financial, linked to the Merger Agreement dated March 26, 2026. Under the agreement, Nippon Life must vote its Corebridge common stock in favor of the merger, subject to limited qualifications, and pursue regulatory approvals. The filing does not state deal value or financial results, so its effect on Equitable shareholders is not quantified here.
Agreement dated April 8, 2026, among Equitable, Corebridge Financial and Nippon Life Insurance Company, filed as Exhibit 10.1
Nippon Life must vote its Covered Stock in favor of the Merger Agreement transactions, subject to certain limited qualifications
At closing, HoldCo and Nippon Life would enter a new Stockholder's Agreement and Registration Rights Agreement, replacing agreements dated December 9, 2024
The Voting and Support Agreement terminates at the earlier of merger closing, merger termination or certain other specified events
Corebridge Financial entered into a Voting and Support Agreement on April 8, 2026, with Nippon Life Insurance Company and Equitable Holdings, Inc. The agreement requires Nippon Life to vote its Corebridge shares in favor of the merger under the March 26, 2026 Merger Agreement, which the filing describes as a proposed transaction between Corebridge and Equitable.
Agreement dated April 8, 2026, tied to the Merger Agreement dated March 26, 2026, among Corebridge, Equitable, and newly formed holding company subsidiaries
Nippon Life must vote its Corebridge common stock in favor of the merger and may not transfer those shares before stockholder approval, subject to exceptions
At closing, Nippon Life and HoldCo will enter new Stockholder's and Registration Rights Agreements replacing the December 9, 2024 agreements
Intel repurchased the 49% equity interest held by Apollo-managed funds and affiliates in its Fab 34 joint venture in Ireland, paying $14.2 billion in cash on hand and a $6.5 billion bridge loan. Intel now owns 100% of the joint venture and expects to terminate the related ancillary agreements and wind up the venture, which the filing describes as a major capital commitment that adds debt Intel intends to refinance subject to market conditions.
Repurchase completed April 8, 2026 under an April 1, 2026 agreement
Purchase price of $14.2 billion financed with cash on hand and a $6.5 billion bridge loan
Apollo-managed funds acquired the 49% stake in June 2024
Intel expects to terminate ancillary agreements and wind up the joint venture
On April 1, 2026, Supernus Pharmaceuticals entered into an asset purchase agreement with Navitor Pharmaceuticals to acquire rights to the compound NV-5138 or SPN-820, including intellectual property, inventory, regulatory materials and certain contract rights. The filing says the price consists of Supernus completing one Phase 2b study and making milestone payments of up to $350 million, and that Supernus can stop pursuing the compound if it judges the study unsuccessful. The filing reports no revenue or earnings figures, so the effect on shareholders depends on the study results and milestone achievement.
Agreement dated April 1, 2026, with Navitor Pharmaceuticals, Inc. and Navitor Pharmaceuticals, LLC
Purchase price: completion of one Phase 2b study plus milestone payments of up to $350 million
Supernus has no further obligation to pursue milestones or commercialization if it judges the post-study result unsuccessful
Agreement is filed as Exhibit 2.1, with some schedules and portions omitted
Capital One Financial completed its previously announced acquisition of Brex Inc. on April 7, 2026, paying approximately $2.56 billion in cash plus 10,646,306 newly issued shares of common stock, subject to a customary post-closing cash adjustment. The same day, the board approved a special award of restricted stock units to Chief Enterprise Services Officer Frank LaPrade, tied to the deal and planned integration work.
Cash consideration of approximately $2.56 billion, subject to customary post-closing adjustment
10,646,306 shares of Capital One common stock issued as stock consideration, exempt from registration under Section 4(a)(2)
Completed April 7, 2026, under a merger agreement dated January 22, 2026
Frank LaPrade received 11,041 RSUs with a grant date value of approximately $2.0 million, vesting in three equal annual installments
SC II Acquisition Corp. entered into a non-binding letter of intent on March 31, 2026, outlining a potential business combination in which it would acquire 100% of the equity of an unnamed payments technology company. The LOI does not commit either party to complete the deal, so shareholders should view it as a preliminary step with no definitive agreement yet.
LOI dated March 31, 2026, with a payments technology company referred to as the Target
Proposed deal would give the Company 100% of the Target's outstanding equity and equity equivalents
Only exclusivity, confidentiality, trust account claim waiver and governing law are binding; no price or terms are disclosed in the filing
Kaltura, Inc. closed its previously announced acquisition of all issued and outstanding share capital of PathFactory Holdings ULC on April 1, 2026. The purchase price is $22,000,000 in total cash consideration, payable at closing, and the filing also refers to future cash and equity purchase price installments without giving amounts.
Closing date: April 1, 2026
Total cash consideration of $22,000,000, payable at closing
Filing refers to future cash and equity purchase price installments, with no amounts or timing given
SWK Holdings Corp became a wholly-owned subsidiary of Runway Growth Finance Corp (RWAY) on April 6, 2026, when the mergers closed. Public common stockholders no longer hold rights as shareholders and instead received merger consideration, with the stock being removed from Nasdaq trading.
Mergers consummated April 6, 2026; trading suspended before market open that day and Nasdaq listing withdrawn
Electing shares reduced by 3,439,429 so Proposed Cash Consideration equaled Aggregate Cash Consideration; proposed cash consideration was $244,352,684.96
First Horizon Bank credit facility terminated and all obligations paid off in full on April 6, 2026
Company plans to file Form 15 to suspend SEC reporting obligations; 9.00% Senior Notes due 2027 ($30.0 million) amended by Second Supplemental Indenture
Howmet Aerospace closed its previously announced purchase of Consolidated Aerospace Manufacturing, LLC, a wholly owned subsidiary of Stanley Black & Decker, on April 6, 2026. The cash price is approximately $1.8 billion, subject to customary adjustments. The filing does not describe the business acquired or its financial results.
Buyer: Howmet Aerospace Inc. (HWM); seller: Stanley Black & Decker, Inc.
Cash purchase price of approximately $1.8 billion, subject to customary adjustments
Transaction completed April 6, 2026 under a Purchase Agreement between the two companies
Neurocrine Biosciences agreed on April 5, 2026 to acquire Soleno Therapeutics through a cash tender offer at $53.00 per share, a total equity value of $2.9 billion. The deal adds VYKAT XR, Soleno's approved treatment for hyperphagia in Prader-Willi syndrome, which generated $190 million of 2025 revenue, to Neurocrine's portfolio. The transaction is expected to close within 90 days, subject to customary conditions including regulatory approvals.
Offer price is $53.00 per Soleno share in cash, a premium of approximately 34% to the April 2, 2026 closing price
Transaction is funded with cash on hand plus a modest amount of pre-payable debt, and is not subject to a financing condition
VYKAT XR generated $190 million in 2025 revenue, including $92 million in the fourth quarter alone
Expected to close within 90 days of the April 6, 2026 announcement, subject to regulatory approvals and tender of a majority of Soleno shares
On March 30, 2026, Crown Reserve Acquisition Corp. I (CRAC) signed a Business Combination Agreement with Carvix, Inc., a Delaware corporation, under which Carvix would merge into a subsidiary of the SPAC and survive as a wholly owned subsidiary. Carvix stockholders would receive 50,000,001 SPAC common shares at closing, plus up to 50,000,100 earnout shares over four years, which would dilute existing SPAC shareholders.
Agreement signed March 30, 2026, with Carvix, Inc.; the SPAC would first domesticate to Delaware.
Carvix stockholders to receive 50,000,001 shares at the Effective Time, plus up to 50,000,100 earnout shares.
Earnout split equally between EBITDA targets (first year $10.38 million) and revenue targets (first year $276.8 million), with payment years starting January 1, 2027.
Either party may terminate if closing has not occurred by September 30, 2026, the Outside Date.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.